FDA Public Workshop to Discuss Emerging Applications of AI in Radiological Imaging
By MedImaging International staff writers Posted on 26 Dec 2019 |
Illustration
The US Food and Drug Administration {(FDA) Silver Spring, MD, USA} has announced a public workshop entitled "Evolving Role of Artificial Intelligence in Radiological Imaging" aimed at discussing emerging applications of Artificial Intelligence (AI) in radiological imaging, including AI devices intended to automate the diagnostic radiology workflow as well as guided image acquisition.
Through the workshop, the FDA intends to work with interested stakeholders to identify the benefits and risks associated with use of AI in radiological imaging. As the benefit-risk profile changes, it is critical to adapt the methods used to evaluate and characterize their performance. The agency also plans to discuss best practices for the validation of AI-automated radiological imaging software and image acquisition devices which is critical to assess their safety and effectiveness. The FDA is also seeking innovative and consistent ways to leverage existing methods and to develop new methods for validation of these AI-based algorithms and explore opportunities for stakeholder collaboration in these efforts.
The public workshop will be held on February 25, 2020 from 8:00 a.m. to 5:30 p.m. (EST) and February 26, 2020 from 9 a.m. to 4:30 p.m. (EST) in Maryland, USA
Related Links:
Food and Drug Administration (FDA)
Through the workshop, the FDA intends to work with interested stakeholders to identify the benefits and risks associated with use of AI in radiological imaging. As the benefit-risk profile changes, it is critical to adapt the methods used to evaluate and characterize their performance. The agency also plans to discuss best practices for the validation of AI-automated radiological imaging software and image acquisition devices which is critical to assess their safety and effectiveness. The FDA is also seeking innovative and consistent ways to leverage existing methods and to develop new methods for validation of these AI-based algorithms and explore opportunities for stakeholder collaboration in these efforts.
The public workshop will be held on February 25, 2020 from 8:00 a.m. to 5:30 p.m. (EST) and February 26, 2020 from 9 a.m. to 4:30 p.m. (EST) in Maryland, USA
Related Links:
Food and Drug Administration (FDA)
Latest Industry News News
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures
- Global Contrast Enhanced Ultrasound Market Driven by Demand for Early Detection of Chronic Diseases